UMIN-CTR History

BACK TOP
UMIN-CTR English Home Glossary (Simple) FAQ Search clinical trials

Name:
UMIN ID:

Unique ID issued by UMIN UMIN000025560
Receipt No. R000029360
Scientific Title A multicenter, phase 1/2 study of Ramucirumab plus Nivolumab as second-line therapy in participants with gastric or GEJ cancer
Date of disclosure of the study information 2017/01/06
Last modified on 2020/04/24 18:07:57

No. Disposal Last modified on Item of update
1 Insert 2017/01/06 13:34:14
2 Update 2017/06/21 18:10:54 Recruitment status
3 Update 2018/01/16 18:56:24 Recruitment status
4 Update 2019/01/11 18:06:13 Last follow-up date
Date analysis concluded
5 Update 2020/04/24 17:06:44 1st name of lead principal investigator
Last name of lead principal investigator
1st name of lead principal investigator
Last name of lead principal investigator
Zip code
Address

Last name of contact person

Last name of contact person
Zip code
Address
Address
Address
Department
Organization
Organization
Address
Address
Tel
Email
6 Update 2020/04/24 17:36:55 Date of IRB
Last follow-up date
Date analysis concluded
7 Update 2020/04/24 17:37:39 Division name
8 Update 2020/04/24 18:07:57 Division name
Institute


Contact us.